Table 1.

Results for ELISA tests rEm18 and Em2-Em18, and rEm18-ICT for AE (alveolar echinococcosis), CE and PE (cystic and polycystic echinococcosis), and other pathologies. Percentages of sensitivity, specificity, and the performance index for each test are shown.

No. of seropositive samples for the three tests
No. of samples rEm18-ICT rEm18-ELISA Em2-Em18-ELISA
AE 30 27 26 29
CE/PE 16 5 4 5
Other 66 1 3 5
Sensitivity, % 90.0 86.7 96.7
(95% CI) (78.4–96.1) (74.4–93.9) (85.8–99.4)
Specificity, % 92.7 91.5 87.8
(95% CI) (88.4–94.9) (87.0–94.1) (83.8–88.8)
Youden index 0.83 0.78 0.85
(95% CI) (0.67–0.91) (0.61–0.88) (0.70–0.88)
Accuracy, % 92.0 90.2 90.2
(95% CI) (85.7–95.2) (83.6–94.1) (84.4–91.6)
Positive likelihood ratio (LR+) 12.3 10.2 7.9
(95% CI) (6.7–18.9) (5.7–16.0) (5.3–8.9)
Negative likelihood ratio (LR−) 0.11 0.15 0.04
(95% CI) (0.04–0.25) (0.06–0.30) (0.01–0.17)
Diagnostic odds ratio 114.0 69.6 208.8
(95% CI) (27.7–461.2) (19.4–248.5) (31.5–1314.4)

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.